-
Australia reeling on 72-4 at lunch as England strike in 4th Ashes Test
-
Too hot to handle? Searing heat looming over 2026 World Cup
-
Packers clinch NFL playoff spot as Lions lose to Vikings
-
Guinea's presidential candidates hold final rallies before Sunday's vote
-
Villa face Chelsea test as Premier League title race heats up
-
Spurs extend domination of NBA-best Thunder
-
Malaysia's Najib to face verdict in mega 1MDB graft trial
-
King Charles calls for 'reconciliation' in Christmas speech
-
Brazil's jailed ex-president Bolsonaro undergoes 'successful' surgery
-
UK tech campaigner sues Trump administration over US sanctions
-
New Anglican leader says immigration debate dividing UK
-
Russia says made 'proposal' to France over jailed researcher
-
Bangladesh PM hopeful Rahman returns from exile ahead of polls
-
Police suspect suicide bomber behind Nigeria's deadly mosque blast
-
AFCON organisers allowing fans in for free to fill empty stands: source
-
Mali coach Saintfiet hits out at European clubs, FIFA over AFCON changes
-
Last Christians gather in ruins of Turkey's quake-hit Antakya
-
Pope Leo condemns 'open wounds' of war in first Christmas homily
-
Mogadishu votes in first local elections in decades under tight security
-
'Starting anew': Indonesians in disaster-struck Sumatra hold Christmas mass
-
Cambodian PM's wife attends funerals of soldiers killed in Thai border clashes
-
Prime minister hopeful Tarique Rahman arrives in Bangladesh: party
-
Pacific archipelago Palau agrees to take migrants from US
-
Pope Leo expected to call for peace during first Christmas blessing
-
Australia opts for all-pace attack in fourth Ashes Test
-
'We hold onto one another and keep fighting,' says wife of jailed Istanbul mayor
-
North Korea's Kim visits nuclear subs as Putin hails 'invincible' bond
-
Trump takes Christmas Eve shot at 'radical left scum'
-
3 Factors That Affect the Cost of Dentures in San Antonio, TX
-
Leo XIV celebrates first Christmas as pope
-
Diallo and Mahrez strike at AFCON as Ivory Coast, Algeria win
-
'At your service!' Nasry Asfura becomes Honduran president-elect
-
Trump-backed Nasry Asfura declared winner of Honduras presidency
-
Diallo strikes to give AFCON holders Ivory Coast winning start
-
Spurs captain Romero facing increased ban after Liverpool red card
-
Bolivian miners protest elimination of fuel subsidies
-
A lack of respect? African football bows to pressure with AFCON change
-
Trump says comedian Colbert should be 'put to sleep'
-
Mahrez leads Algeria to AFCON cruise against Sudan
-
Southern California braces for devastating Christmas storm
-
Amorim wants Man Utd players to cover 'irreplaceable' Fernandes
-
First Bond game in a decade hit by two-month delay
-
Brazil's imprisoned Bolsonaro hospitalized ahead of surgery
-
Serbia court drops case against ex-minister over train station disaster
-
Investors watching for Santa rally in thin pre-Christmas trade
-
David Sacks: Trump's AI power broker
-
Delap and Estevao in line for Chelsea return against Aston Villa
-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
Japanese researchers test pioneering drug to regrow teeth
People with missing teeth may be able to grow new ones, say Japanese dentists testing a pioneering drug they hope will offer an alternative to dentures and implants.
Unlike reptiles and fish, which usually replace their fangs on a regular basis, it is widely accepted that humans and most other mammals only grow two sets of teeth.
But hidden underneath our gums are the dormant buds of a third generation, according to Katsu Takahashi, head of oral surgery at the Medical Research Institute Kitano Hospital in Osaka.
His team launched clinical trials at Kyoto University Hospital in October, administering an experimental medicine to adult test subjects that they say has the potential to jumpstart the growth of these concealed teeth.
It's a technology "completely new" to the world, Takahashi told AFP.
Prosthetic treatments used for teeth lost to decay, disease or injury are often seen as costly and invasive.
So "restoring natural teeth definitely has its advantages", said Takahashi, the project's lead researcher.
Tests on mice and ferrets suggest that blocking a protein called USAG-1 can awaken the third set, and the researchers have published lab photographs of regrown animal teeth.
In a study published last year, the team said their "antibody treatment in mice is effective for tooth regeneration and can be a breakthrough in treating tooth anomalies in humans".
- 'Only the beginning' -
For now, the dentists are prioritising the "dire" needs of patients with six or more permanent teeth missing from birth.
The hereditary condition is said to affect around 0.1 percent of people, who can have severe trouble chewing, and in Japan often spend most of their adolescence wearing a face mask to hide the wide gaps in their mouth, Takahashi said.
"This drug could be a game-changer for them," he added.
The drug is therefore aimed primarily at children, and the researchers want to make it available as early as 2030.
Angray Kang, a dentistry professor at Queen Mary University of London, only knows of one other team pursuing a similar objective of using antibodies to regrow or repair teeth.
"I would say that the Takahashi group is leading the way," the immunotechnology expert, who is not connected to the Japanese research, told AFP.
Takahashi's work is "exciting and worth pursuing", Kang said, in part because an antibody drug that targets a protein nearly identical to USAG-1 is already being used to treat osteoporosis.
"The race to regenerate human teeth is not a short sprint, but by analogy a set of back-to-back consecutive ultra-marathons," he said.
"This is only the beginning."
Chengfei Zhang, a clinical professor in endodontics at the University of Hong Kong, said Takahashi's method is "innovative and holds potential".
"The assertion that humans possess latent tooth buds capable of producing a third set of teeth is both revolutionary and controversial," he told AFP.
He also cautioned that "outcomes observed in animals do not always directly translate to humans".
The results of the animal experiments raise "questions about whether regenerated teeth could functionally and aesthetically replace missing teeth", Zhang added.
- 'Over the moon' -
A confident Takahashi argues that the location of a new tooth in a mouth can be controlled, if not pinpointed, by the drug injection site.
And if it grows in the wrong place, it can be moved through orthodontics or transplantation, he said.
No young patients with the congenital disorder are taking part in the first clinical trial, as the main objective is to test the drug's safety, rather than its effectiveness.
So for now, the participants are healthy adults who have lost at least one existing tooth.
And while tooth regeneration is not the express goal of the trial this time around, there is a slim chance that it could happen to subjects anyway, Takahashi said.
If so, the researchers will have confirmed that the drug can be effective for those with acquired toothlessness -- which would be a medical triumph.
"I would be over the moon if that happens," Takahashi said.
This could be particularly welcome news in Japan, which has the second-oldest population in the world.
Health ministry data shows more than 90 percent of people aged 75 or older in Japan have at least one tooth missing.
"Expectations are high that our technology can directly extend their healthy life expectancy," Takahashi said.
F.Pedersen--AMWN